Furthermore, GHK-Cu has demonstrated neuroprotective properties and can promote the growth of new neurites, potentially enhancing cognitive function and protecting against age-related decline
Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS
Tirzepatide is a different molecule and can produce different GI symptoms than semaglutide, so starting at 2.5mg and titrating up gives your body a chance to adjust
Fitzpatrick IV through VI skin tones respond well to GHK-Cu microinfusion at the standard depth and cadence, with one important adjustment: extra attention to sun protection in the 72 hours after each session
[1] [2] The pivotal clinical trials evaluating tirzepatide for type 2 diabetes (SURPASS programme) and obesity (SURMOUNT programme) did not identify hot flushes as a significant treatment-emergent adverse event
The glucagon component's effect on liver metabolism warrants caution in those with existing liver disease